Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer

Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer

Hui Shi,1,* Haidong Huang,1,* Jin Pu,2 Dongchen Shi,1 Yunye Ning,1 Yuchao Dong,1 Yiping Han,1 Paul Zarogoulidis,3 Chong Bai1 1Department of Respiratory and Critical Care Medicine, Changhai Hospital Affiliated to The Second Military Medical University, Shanghai 200433, People’s Republic of...

Full description

Bibliographic Details
Main Authors: Shi H, Huang H, Pu J, Shi DC, Ning Y, Dong Y, Han Y, Zarogoulidis P, Bai C
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:OncoTargets and Therapy
Subjects:
NSCLC
apolipoprotein A-I
metastasis
prognosis
Online Access:https://www.dovepress.com/decreased-pretherapy-serum-apolipoprotein-a-i-is-associated-with-exten-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/decreased-pretherapy-serum-apolipoprotein-a-i-is-associated-with-exten-peer-reviewed-article-OTT

Similar Items